ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of care and rheumatoid arthritis (RA)"

  • Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting

    Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment

    Claire Barber1, Diane Lacaille2, Peter Faris3, Dianne P. Mosher4, Steven J. Katz5, Joanne Homik6, Jatin Patel7, Sharon Zhang7, Cheryl Barnabe8, Glen Hazlewood9, Vandana Ahluwalia10, Natalie J. Shiff11, Vivian P. Bykerk12, Marinka Twilt13, Susanne Benseler14, Jennifer Burt15 and Deborah A. Marshall16, 1Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Arthritis Research Canada/University of British Columbia, Medicine/Rheumatology, Richmond, BC, Canada, 3Alberta Health Services, Alberta, AB, Canada, 4Med, University of Calgary, Calgary, AB, Canada, 5Rheumatology, University of Alberta, Edmonton, AB, Canada, 6University of Alberta, Edmonton, AB, Canada, 7Alberta Health Services, Calgary, AB, Canada, 8Medicine, University of Calgary, Calgary, AB, Canada, 9Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, 10William Osler Health Center, Brampton, ON, Canada, 11University of Florida, Gainesville, FL, 12Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, 13University of Calgary, Calgary, AB, Canada, 14Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 15St. Clare's Mercy Hospital, Eastern Health, St. John's, NF, Canada, 16Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…
  • Abstract Number: 1166 • 2016 ACR/ARHP Annual Meeting

    Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis

    Mie Fusama1, Kayoko Higashi1, Keiji Maeda2, Norikazu Murata3 and Hideko Nakahara2, 1Division of Nursing, NTT West Osaka Hospital, Osaka, Japan, 2NTT West Osaka Hospital, Osaka, Japan, 3Yukioka Hospital, Osaka, Japan

    Background/Purpose:  In order to achieve treatment goals in patients with rheumatoid arthritis (RA), the guidance for “treatment to target (T2T) by measuring disease activity and…
  • Abstract Number: 1492 • 2015 ACR/ARHP Annual Meeting

    Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat

    Louise Grech1,2, Anthony Serracino Inglott1, Victor Ferrito1 and Lilian M. Azzopardi1, 1Department of Pharmacy, University of Malta, Msida, Malta, 2Clinical Pharmacy Practice Unit, Department of Pharmacy, Mater Dei Hospital, Msida, Malta

    Background/Purpose: The RhMAT is a medication assessment tool developed to specifically analyse pharmacotherapy adherence to evidence based medicine and guidelines on the management of rheumatoid…
  • Abstract Number: 2306 • 2014 ACR/ARHP Annual Meeting

    Quality of Care for Cardiovascular Prevention in RA: Compliance with Diabetes Screening Guidelines

    Timothy J Schmidt1,2, J Antonio Avina-Zubieta2,3,4, Eric C. Sayre3, Michal Abrahamowicz5, John M. Esdaile2,6,7 and Diane Lacaille8,9,10, 1Arthritis Research Centre of Canada, Richmind, BC, Canada, 2Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 5Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 6Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 7Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 8Arthritis Research Centre of Canada, Vancouver, BC, Canada, 9Medicine, University of British Columbia, Vancouver, BC, Canada, 10University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada

    Background/Purpose: Comorbidities are increasingly recognized as significant contributors of decreased quality of life, and increased mortality in RA. RA is associated with an increased risk…
  • Abstract Number: 2308 • 2014 ACR/ARHP Annual Meeting

    Quality of Care for Cardiovascular Disease Prevention in RA: Compliance Lipid Screening Guidelines

    Timothy J Schmidt1,2, J Antonio Avina-Zubieta3,4,5, Eric C. Sayre4, Michal Abrahamowicz6, John M. Esdaile3,7,8 and Diane Lacaille9,10,11, 1Arthritis Research Centre of Canada, Richmind, BC, Canada, 2Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Richmond, BC, Canada, 3Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, 4Arthritis Research Centre of Canada, Richmond, BC, Canada, 5Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 6Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 7Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 8Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 9Medicine, University of British Columbia, Vancouver, BC, Canada, 10Arthritis Research Centre of Canada, Vancouver, BC, Canada, 11University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada

    Background/Purpose: Comorbidities are increasingly recognized as significant contributors of reduced quality of life and increased mortality in RA. Cardiovascular diseases are the leading cause of…
  • Abstract Number: 1351 • 2014 ACR/ARHP Annual Meeting

    Assessment of ACR Endorsed Quality Indicators in Rheumatoid Arthritis Patients – a Quality Improvement Initiative

    Puneet Bajaj1, Erik Anderson2, Siddharth Raghavan2, Asha Patnaik1 and Heidi Roppelt1, 1Rheumatology, Stony Brook University Medical Center, East Setauket, NY, 2Internal Medicine, Stony Brook University Medical Center, East Setauket, NY

    Background/Purpose: Quality assessments are being increasingly used for quality improvement, accountability, and performance based incentives. The current research regarding quality of care provided to rheumatoid…
  • Abstract Number: 1350 • 2014 ACR/ARHP Annual Meeting

    Practice What You Preach? Suboptimal Guideline Adherence By Rheumatologists in Patients with Rheumatoid Arthritis

    Nienke Lesuis1, Ronald van Vollenhoven2, Marlies Hulscher3 and Alfons den Broeder1, 1Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 3IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Tight control based treatment principles of rheumatoid arthritis (RA) are superior to usual care and therefore recommended in many (inter)national guidelines.1-3 Unfortunately guideline adherence…
  • Abstract Number: 1711 • 2013 ACR/ARHP Annual Meeting

    Folic Acid Prescription Among Older Adult Methotrexate Initiators Is Poor

    Gabriela Schmajuk1, Jinoos Yazdany2, Yinghui Miao3, David I. Daikh4 and Michael Steinman3, 1Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Division of Geriatrics, UCSF, San Francisco Veterans Affairs Medical Center, San Francisco, CA, 4Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Methotrexate (MTX) is the most commonly used disease modifying agent for rheumatoid arthritis (RA), although liver enzyme (LFT) elevations limit its use in some…
  • Abstract Number: 2511 • 2012 ACR/ARHP Annual Meeting

    Potential Barriers That Limit Access to Rheumatologists Among Patients with Early Rheumatoid Arthritis in a Universal Access Health Care System

    Jessica Widdifield1, J. Michael Paterson2, Sasha Bernatsky3, Karen Tu2, Nadia Gunraj2, Noah Ivers1, Debra Butt2, R. Liisa Jaakkimainen4, J. Carter Thorne5, Vandana Ahluwalia6 and Claire Bombardier7, 1University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 4Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, 5Southlake Regional Health Centre, Newmarket, ON, Canada, 6William Osler Health Center, Brampton, ON, Canada, 7Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Current guidelines for the optimal care of rheumatoid arthritis (RA) recommend prompt referral to a rheumatologist. In the province of Ontario, Canada all 13…
  • Abstract Number: 2061 • 2012 ACR/ARHP Annual Meeting

    Physician Variation in Documentation of Rheumatoid Arthritis Quality Measures and Evaluation of Relationship with Radiographic Progression

    Sonali Desai1, Jinoos Yazdany2, Nancy A. Shadick3, Siri Lillegraven4, Chih-Chin Liu5, Michelle A. Frits6, Tabatha Norton7, Jonathan S. Coblyn8, Michael Weinblatt5 and Daniel H. Solomon9, 1Medicine/ Rheumatology, Boston, MA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 4Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, 6Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 7Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 8Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 9Division of Rheumatology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Documentation of quality measures (QMs) in rheumatoid arthritis (RA) has been proposed as a way to demonstrate quality of care, but data linking appropriate…
  • Abstract Number: 2051 • 2012 ACR/ARHP Annual Meeting

    Standardized Data Collection Supports Reliable Reporting of Rheumatoid Arthritis (RA) Measures for the Medicare Physicians’ Quality Reporting System

    J. Timothy Harrington1, George Reed2, Katherine C. Saunders3, Lisa Lemire4, Aimee Whitworth4, Jeffrey D. Greenberg5 and Joel M. Kremer6, 1Joiner Associates LLC, Madison, WI, 2Division of Behavioral and Preventive Medicine, University of Massachusetts Medical School, Worcester, MA, 3Corrona, LLC., Southborough, MA, 4CORRONA, Inc., Southborough, MA, 5New York Hospital for Joint Disease, New York, NY, 6Albany Medical College and The Center for Rheumatology, Albany, NY

    Background/Purpose: The Medicare Physicians' Quality Reporting System (PQRS) program encourages physicians to measure and report clinical processes and disease outcomes that correlate with quality care,…
  • Abstract Number: 1822 • 2012 ACR/ARHP Annual Meeting

    Liver Toxicity Monitoring and Its Impact On Methotrexate Discontinuation in a National Cohort of Veterans

    Gabriela Schmajuk1, Yinghui Miao2, Jinoos Yazdany3, Mary Margaretten4 and Michael Steinman2, 1Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, 2Division of Geriatrics, UCSF, San Francisco Veterans Affairs Medical Center, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: The National Quality Forum recently endorsed a controversial quality measure that assesses liver toxicity monitoring for patients receiving oral methotrexate (MTX).  Using national data…
  • Abstract Number: 1667 • 2012 ACR/ARHP Annual Meeting

    Impact of Rheumatoid Arthritis On Recognition of Hypertension in a Medically Homed Population

    Christie M. Bartels1, Heather Johnson2, Katya Voelker3, Patrick Mc Bride4 and Maureen Smith5, 1Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Univ of Wisconsin School of Medicine and Public Health, Madison, AA, 4Cardiology/Medicine, Univ of Wisconsin School of Medicine and Public Health, Madison, WI, 5Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Impact of Rheumatoid Arthritis on Recognition of Hypertension in a Medically Homed PopulationBackground/Purpose: Numerous studies report increased cardiovascular disease (CVD) events and others describe increased…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology